Brief: Sensei Biotherapeutics To Present New Data For SNS-101 At The Society For Immunotherapy Of Cancer
01/10/2021 13:24
Oct 1 (Reuters) - Sensei Biotherapeutics Inc SNSE.O :
* SENSEI BIOTHERAPEUTICS TO PRESENT NEW PRECLINICAL DATA FOR
SNS-101, A PROPRIETARY ANTI-VISTA ANTIBODY, AT THE 36TH ANNUAL
MEETING OF THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC)
Source text for Eikon: ID:nGNX6fktb9
Further company coverage: SNSE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Faeth Therapeutics
See all newsU.S. STOCKS ON THE MOVE - Nvidia, Gold miners, Nike
U.S. STOCKS ON THE MOVE - Sunrun, JetBlue Airways, Dell Technologies
Faeth Therapeutics rises after FDA grants fast-track status for cancer drug
Brief: Faeth Therapeutics Announces FDA Grant Of Fast Track Designation For Piktor Plus Paclitaxel In Biomarker-Selected Advanced Endometrial Cancer
Brief: Faeth Therapeutics Strengthens Executive Team With Senior Leadership Appointments